The gene editing system CRISPR-Cas9 is promising for its potential to treat diseases caused by gene irregularities, but fears of off-target effects threaten to…
Welcome to the latest edition of our weekly EuroBiotech Report. We start this week with the EMA, which warned that it may lose 30% of its staff in its move to…
FOXP2, a gene implicated in affecting speech and language, is held up as a textbook example of positive selection on a human-specific trait. But in a paper…
The study on the global Marine Biotechnology Market 2018 is a thorough examination that offers an exclusive merger of expert market facts. The study shows…
NewLink has cut its headcount by a third to buy the time it needs to prove that—despite setbacks—its IDO inhibitor indoximod is still worth pursuing.
The…
As biologists have probed deeper into the molecular and genetic underpinnings of life, K-12 schools have struggled to provide a curriculum that reflects those…